Quick Takeaways
- Jason Tardio has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $70,353.
- Recent insider filing activity is available below.
Insider Trading & Ownership of Jason Tardio
- Location
- New York, NY
- Summary
- The estimated net worth of Jason Tardio is at least $70,353 dollars as of 18 Jul 2025. Jason Tardio is the Chief Operating Officer of Ovid Therapeutics Inc. and owns shares of Ovid Therapeutics Inc. (OVID) stock worth about $60.5K. Jason Tardio is the President and COO of IMMUNIC, INC. and owns shares of IMMUNIC, INC. (IMUX) stock worth about $9.9K.
- Signature
- /s/ Jason Tardio
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Jason Tardio and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Ovid Therapeutics Inc. ($60,469).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Jason Tardio
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| OVID | Ovid Therapeutics Inc. | Chief Operating Officer | $60,469 | 22 Feb 2024 | ||
| IMUX | IMMUNIC, INC. | President and COO | $9,884 | +$9,884 | +100% | 16 Jul 2025 |
Insider Transactions Reported by Jason Tardio:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.